Is DASTY a Buy or a Sell? The Bull and Bear Case (2026)

Last updated October 2026

Short answer

Both cases are real, which is why the question is contested. The bull case for Dassault Systèmes SE (DASTY) rests on Subscription and cloud transition: Dassault has historically sold perpetual licences plus maintenance, and it is now pushing customers toward subscriptions and the 3DEXPERIENCE cloud. The bear case rests on revenue growth has slowed to the low-to-mid single digits, and a further guidance cut would likely weigh on a stock that has already de-rated sharply. Analysts covering it publish targets from $19.06 to $28.93 against a $25.94 price, so even the professionals disagree by 38% of their own average. We do not give a verdict. What follows is each case at full strength, so you can decide which set of assumptions you actually believe. Walnut is not an investment adviser.

Dassault Systemes SE is a Paris-based software company, listed on Euronext Paris (ticker DSY) and available to US investors as the DASTY American Depositary Receipt. It sells the tools manufacturers and life-sciences companies use to design, simulate, build and manage products: CATIA for 3D design in aerospace and automotive, SIMULIA for simulation, DELMIA for manufacturing operations, ENOVIA for product lifecycle management, SOLIDWORKS for small and mid-sized engineering firms, and Medidata, acquired in 2019 for ~$5.8 billion, which runs clinical-trial data for drugmakers. These products increasingly sit on a common cloud platform the company calls 3DEXPERIENCE, which it frames as a "virtual twin" of a product, a factory or even a patient. Revenue in 2025 was ~EUR 6.24 billion (~$7.1 billion), up ~4% in constant currency, with non-IFRS operating margins around 32% and non-IFRS diluted EPS of ~EUR 1.31. Pascal Daloz has been chief executive since 2024, succeeding long-time leader Bernard Charles, who remains chairman. The investment picture changed sharply in February 2026. Fourth-quarter 2025 revenue grew only ~1%, and management guided 2026 revenue growth to 3% to 5% in constant currency, below the 4% to 7% range many investors had pencilled in. The Paris shares fell ~20% in a single session, reportedly their worst day on record, after an earlier ~12% drop in October 2025 when the company trimmed its 2025 revenue outlook. The weak spot is Life Sciences, where revenue fell ~2% in 2025 as pharma companies started fewer trials, while Industrial Innovation (CATIA and peers) kept growing mid-to-high single digits. Second-quarter 2026 results were steadier: revenue of ~EUR 1.56 billion, up ~4%, subscription up ~8%, 3DEXPERIENCE and cloud software both up ~14%, and annual run rate up ~6% to ~EUR 4.44 billion, with full-year targets confirmed. The company also agreed to buy ArisGlobal, a drug-safety and regulatory software vendor, for ~$1.8 billion in cash plus up to ~$200 million in earn-outs. At ~EUR 20 to 22 per share in early October 2026, against a 52-week range of roughly EUR 16 to 30, the stock trades near ~20x trailing earnings, a large discount to its own history and to US design-software peers.

The bull case: what would have to be true for $28.93

The most optimistic published target on DASTY is $28.93, +11.5% from the $25.94 price as of October 2026. Getting there needs the following to work close to its best case, not merely to avoid going wrong.

1. Subscription and cloud transition

Dassault has historically sold perpetual licences plus maintenance, and it is now pushing customers toward subscriptions and the 3DEXPERIENCE cloud. Subscription revenue grew ~11% in 2025 and ~8% in Q2 2026, and 3DEXPERIENCE and cloud software each grew ~14% in the latest quarter. This shift depresses reported growth in the short run, because upfront licence revenue is replaced by smaller recurring fees, but it raises visibility and lifetime customer value. The new annual run rate disclosure (~EUR 4.44 billion, up ~6%) is meant to let investors track that recurring base directly. If the transition matures, the reported growth rate could converge upward toward the recurring growth rate.

2. Industrial Innovation and aerospace demand

The CATIA, SIMULIA, DELMIA and ENOVIA franchise is the company's largest and most profitable engine, and it grew ~6% in 2025. Aerospace and defence programmes, electric and software-defined vehicles, and reshoring of manufacturing all require new design and simulation work, which tends to lock customers into multi-decade relationships. CATIA is effectively the standard at Airbus, Boeing and many automakers, giving Dassault strong switching-cost protection. A pickup in defence spending in Europe and continued aerospace production ramps are tailwinds; a slowdown in automotive investment, particularly in Germany and China, is the main offset.

3. Life Sciences recovery and ArisGlobal

Medidata was the growth story of the late 2010s, but Life Sciences revenue slipped ~2% in 2025 as biotech funding tightened and large pharma companies started fewer studies. Management is betting that a broader platform, linking trial design, patient data and now drug-safety and regulatory workflows through ArisGlobal, can restore growth and raise share of wallet. The ArisGlobal deal (~$1.8 billion cash, funded from existing reserves, expected to close in the second half of 2026) is guided as accretive to revenue and EPS in year one. Whether trial starts recover is largely outside Dassault's control, so this segment is the swing factor for the overall growth rate.

4. AI-native platform and virtual companions

Dassault is repositioning 3DEXPERIENCE as an AI-native, agentic platform, adding "Virtual Companion" skills intended to co-engineer alongside human designers, plus generative tools for design exploration and simulation. The argument is that decades of proprietary engineering data and physics-based simulation give it an edge that general-purpose AI models lack. If these features command higher pricing or pull more users onto cloud subscriptions, they could support the margin and growth targets. The counterpoint is that AI could also lower barriers for new entrants and pressure per-seat pricing over time.

The bear case: what would have to be true for $19.06

The most pessimistic published target is $19.06, -26.5% from the current price. That is not a floor and not a forecast; it is roughly what one analyst thinks Dassault Systèmes SE is worth if the risks below bite instead of the drivers above.

Revenue growth has slowed to the low-to-mid single digits, and a further guidance cut would likely weigh on a stock that has already de-rated sharply. Life Sciences depends on pharma trial activity and biotech funding, which can stay weak for several years, and the ArisGlobal integration adds execution and goodwill risk on top of the Medidata experience. Competition is intense from Siemens Digital Industries Software, PTC and Autodesk, and AI-driven design tools could erode pricing. Automotive exposure (Europe and China) and US tariffs on industrial goods could delay customer projects. For US holders of DASTY, euro-dollar moves, French dividend withholding and thinner OTC liquidity add layers of return variability beyond the business itself.

The bear case deserves the same attention as the bull case, and usually gets less. If you are holding DASTY already, the question is not whether these risks exist but whether any of them has moved from possible to actually happening in the reported numbers.

Where analysts land on DASTY

4 analysts cover DASTY, with an average target of $26.09 (+0.6% against $25.94) and a split of 2 buy, 1 hold, 1 sell. Bear in mind sell-side ratings skew positive across the whole market, so that split is not a balanced vote. The full target table, the recent rating actions by firm, and how the consensus has shifted are on the DASTY forecast and price target page.

How is DASTY valued? (as of October 2026)

Price
$25.94
Market cap
$34.09B
P/E (TTM)
22.96
Forward P/E
16.48
Price / book
3.28
Beta
0.57
52-week range
$18.99 to $35.20

Snapshot for DASTY as of October 2026, sourced from Yahoo Finance and may be delayed. Valuation figures move with price and earnings; verify the current numbers with your broker before deciding.

  • Revenue (FY2025): ~EUR 6.24B (~$7.1B), +4% cc
  • 2026 revenue guidance: ~EUR 6.30B to 6.42B (+3% to 5% cc)
  • Non-IFRS operating margin: ~32% (2026 guide 32.2% to 32.6%)
  • Non-IFRS diluted EPS: ~EUR 1.31 (2025); 2026 guide EUR 1.30 to 1.34
  • Market cap: ~EUR 26B to 29B (~$30B to 34B)
  • Valuation: ~20x trailing EPS; ~16x 2026 non-IFRS EPS

Figures are approximate and in euros, the company's reporting currency; USD conversions assume roughly 1.15 to 1.17 dollars per euro. Non-IFRS EPS excludes acquisition amortisation and share-based compensation, so IFRS EPS is materially lower (~EUR 0.90 in 2025), and the trailing multiple depends heavily on which basis a data provider uses. Third-quarter 2026 results are expected in late October 2026, with Q3 guidance of ~EUR 1.50B to 1.54B in revenue, and the ArisGlobal deal is excluded from the current outlook.

How do you decide if DASTY is a buy?

Rather than asking whether DASTY is a buy in the abstract, it tends to help to answer four questions:

  • Thesis: do you believe the bull case above, and is it still true today?
  • Time horizon: a single stock can be volatile, so a longer horizon absorbs more of the swings.
  • Position sizing: a thesis can be right and the sizing still wrong; decide how much of your portfolio one name should be.
  • Overlap: check whether you already hold DASTY indirectly through an index or sector ETF before adding more.

What would change your mind on DASTY

Write the tripwires down before you need them. Deciding what would falsify your view is far harder once a position is moving against you.

  • Bull case breaks if: Subscription and cloud transition stalls in the reported numbers rather than in the narrative around them.
  • Bear case breaks if: revenue growth has slowed to the low-to-mid single digits, and a further guidance cut would likely weigh on a stock that has already de-rated sharply fails to materialise over several reporting periods while the drivers keep compounding.
  • Neither matters if: the position has grown large enough that being wrong would damage the whole portfolio. Sizing overrides the argument.

For the full picture, see the DASTY stock guide (what the company does, the ETFs that hold it, similar stocks, and the themes it fits). In Walnut you can ask its AI about DASTY against your real portfolio and see your actual exposure before deciding.

Investing in Dassault Systèmes SE with AI

Connect the broker you already use and ask Walnut's AI how DASTY fits what you actually hold: whether you own it already through a fund, what it would do to your concentration, and how it has tracked the S&P 500. Read-only by default, and you approve anything before it reaches your broker.

FAQ

Is DASTY a good stock to buy right now?

+

That depends on which case you find more convincing, and both are on this page. The bull case rests on Subscription and cloud transition, with revenue (fy2025) at ~EUR 6.24B (~$7.1B), +4% cc. The bear case rests on revenue growth has slowed to the low-to-mid single digits, and a further guidance cut would likely weigh on a stock that has already de-rated sharply. Analysts covering it are spread from $19.06 to $28.93, which is itself a signal that this is genuinely contested. If you believe the thesis, the real questions become sizing and overlap rather than timing. Walnut is not an investment adviser and this is not a recommendation.

Should I sell DASTY?

+

Nobody can answer that for you, and the honest version of the question is narrower: has anything changed in the reason you bought it? The bear case on this page is the place to check. Revenue growth has slowed to the low-to-mid single digits, and a further guidance cut would likely weigh on a stock that has already de-rated sharply. If that risk is what you were worried about and it is now playing out, that is a real signal. If the price simply fell while the thesis held, that is a different situation entirely. The most pessimistic published target is $19.06, -26.5% from the $25.94 price, which is one analyst's downside case rather than a floor. Walnut is not an investment adviser.

What is the bull case for DASTY?

+

Subscription and cloud transition. Dassault has historically sold perpetual licences plus maintenance, and it is now pushing customers toward subscriptions and the 3DEXPERIENCE cloud. The most optimistic analyst target on DASTY is $28.93, +11.5% from the $25.94 price. That figure is only reachable if this thesis works close to its best case.

What is the bear case for DASTY?

+

Revenue growth has slowed to the low-to-mid single digits, and a further guidance cut would likely weigh on a stock that has already de-rated sharply. Life Sciences depends on pharma trial activity and biotech funding, which can stay weak for several years, and the ArisGlobal integration adds execution and goodwill risk on top of the Medidata experience. Competition is intense from Siemens Digital Industries Software, PTC and Autodesk, and AI-driven design tools could erode pricing. Automotive exposure (Europe and China) and US tariffs on industrial goods could delay customer projects. For US holders of DASTY, euro-dollar moves, French dividend withholding and thinner OTC liquidity add layers of return variability beyond the business itself. The most pessimistic published target is $19.06, -26.5% from the current price, which is roughly what the stock is worth if these risks bite rather than the drivers.

What does Dassault Systèmes SE do?

+

Paris-based maker of 3D design, simulation and product-lifecycle software, including CATIA and SOLIDWORKS.

What would have to change for DASTY to stop being worth holding?

+

Decide that in advance, because it is far harder to think clearly once a position is moving against you. The concrete tripwires here: the driver behind the bull case (Subscription and cloud transition) stalling in the reported numbers rather than in the narrative, the risk above (revenue growth has slowed to the low-to-mid single digits, and a further guidance cut would likely weigh on a stock that has already de-rated sharply) turning from a possibility into a reported fact, or the position growing large enough that a bad outcome would matter to your whole portfolio regardless of who is right.

What is DASTY and how does the ADR work?

+

DASTY is a sponsored American Depositary Receipt for Dassault Systemes SE, traded over the counter in the US rather than on the NYSE or Nasdaq. Each DASTY ADR represents one ordinary share (a 1:1 ratio), and the primary listing is on Euronext Paris under the ticker DSY, where most trading volume occurs. The ADR price is essentially the Paris price converted into dollars, so it moves with both the share price and the euro-dollar exchange rate. Because it trades OTC, bid-ask spreads can be wider than for a US-listed stock, and intraday price discovery leans on Paris trading hours. The 2021 five-for-one share split was applied to both the ordinary shares and the ADR.

How does currency exposure affect a DASTY holder?

+

Dassault reports in euros and its shares are priced in euros in Paris, so a US holder of DASTY carries euro exposure on top of the stock's own performance. If the euro strengthens against the dollar, the ADR rises in dollar terms even with a flat Paris price, and the reverse applies when the dollar strengthens. The business itself is global, with a large share of revenue from the Americas and Asia, so currency also affects reported results: the company reports growth in constant currency to strip this out. Over a single year, euro-dollar swings of 5% to 10% are common and can be a meaningful part of the ADR's total return.

Does Dassault Systemes pay a dividend, and how is it taxed for US holders?

+

Dassault pays a modest annual dividend, roughly EUR 0.26 to 0.28 per share in recent years, which works out to a yield of only ~1% to 1.5% at current prices; the company prioritises reinvestment, acquisitions and buybacks over payouts. Dividends are paid once a year, typically in late May or June after the annual general meeting, and the depositary converts them into dollars for ADR holders after fees. France applies a withholding tax on dividends paid to non-residents (a 25% headline rate, reducible to 15% under the US-France tax treaty with the right paperwork). US investors may be able to claim a foreign tax credit, which depends on their individual situation and account type.

Walnut is informational, not investment advice, and gives no verdict on DASTY. Analyst targets referenced here come from a October 2026 pull of published third-party research and change constantly. Verify current figures with your broker before acting on them.

The case for and against similar stocks